Sign up for our daily briefing
Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Denver news in your inbox
Catch up on the most important stories affecting your hometown with Axios Denver
Des Moines news in your inbox
Catch up on the most important stories affecting your hometown with Axios Des Moines
Minneapolis-St. Paul news in your inbox
Catch up on the most important stories affecting your hometown with Axios Twin Cities
Tampa Bay news in your inbox
Catch up on the most important stories affecting your hometown with Axios Tampa Bay
Charlotte news in your inbox
Catch up on the most important stories affecting your hometown with Axios Charlotte
John Arnold, a former energy trader and hedge fund manager, is putting up millions of dollars to fight the pharmaceutical industry over drug prices, the Wall Street Journal reports.
By the numbers: Arnold has given $19 million to ICER, the independent organization that studies whether drugs are worth what they cost.
- Arnold and his wife have pledged another $5.7 million to I-MAK, an organization that challenges patents of brand name drugs.
- Another $1 million went to Civica Rx, the drugmaker founded by a consortium of hospitals to produce generic drugs.
- Arnold's foundation also funds the advocacy group Patients for Affordable Drugs, which has taken on industry allies from both political parties.
Why it matters: The pharmaceutical industry is so powerful and has remained free from political intervention for so long, in part because it's enormously well-funded — both in its direct lobbying and in its advocacy work.
- No one person is likely to outmatch the entire drug industry, but Arnold's foundation controls assets of more than $2 billion, per WSJ. That's more than the Red Cross — and enough to provide a credible counterweight to pharma.